Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphotyrosyl phosphatase activator
(
PTPA
) is decreased in the brains of Alzheimer's disease (AD) and the AD transgenic mouse models. Here, we investigated whether down-regulation of
PTPA
affects cell viability and the underlying mechanisms. We found that
PTPA
was located in the integral membrane of mitochondria, and knockdown of
PTPA
induced cell apoptosis in HEK293 and N2a cell lines.
PTPA
knockdown decreased mitochondrial membrane potential and induced Bax translocation into the mitochondria with a simultaneous release of Cyt C, activation of caspase-3, cleavage of poly (DNA ribose) polymerase (
PARP
), and decrease in Bcl-xl and Bcl-2 protein levels. Over-expression of Protein phosphatase 2A (PP2A) catalytic subunit (PP2AC ) did not rescue the apoptosis induced by
PTPA
knockdown, and
PTPA
knockdown did not affect the level of and their phosphorylation of mitogen-activated protein kinases (MAPKs), indicating that PP2A and MAPKs were not involved in the apoptosis induced by
PTPA
knockdown. In the cells with over-expression of tau,
PTPA
knockdown induced PP2A inhibition and tau hyperphosphorylation but did not cause significant cell death. These data suggest that
PTPA
deficit causes apoptotic cell death through mitochondrial pathway and simultaneous tau hyperphosphorylation attenuates the
PTPA
-induced cell death.
Phosphotyrosyl phosphatase activator
(
PTPA
) is decreased in the brains of Alzheimer's disease (AD) and AD transgenic mouse models. Here, we investigated whether down-regulation of
PTPA
affects cell viability. We found that
PTPA
located in the integral membrane of mitochondria, and knockdown of
PTPA
induced cell apoptosis in HEK293 and N2a cell lines by decreasing mitochondrial membrane potential, which leads to translocation of Bax and a simultaneous release of Cyt C. In the cells with tau over-expression,
PTPA
knockdown inactivated PP2A to phosphorylate tau to avoid cell apoptosis which induced by
PTPA
knockdown.
...
PMID:Knockdown of phosphotyrosyl phosphatase activator induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation. 2482 Dec 82